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Available online 22 February 2014AbstractSpontaneous intramural small-bowel hematoma secondary to warfarin therapy has been reported in the literature, but this complication of
anticoagulant therapy is still considered rare. Here we report two cases of spontaneous nontraumatic jejunal intramural hematoma treated in our
institution. After emergent admission for acute abdomen, both cases were found to have a history of warfarin therapy for atrial fibrillation.
Prothrombin time, activated partial thromboplastin time, and international normalized ratio were elevated in both cases. For Case 1, abdominal
computed tomography revealed segmental mural thickening with precontrast hyperdensity and perienteric haziness affecting the distal jejunum.
The patient underwent emergent laparotomy under the impression of mesentery occlusion with impending bowel ischemia due to her history of
atrial fibrillation. Abdominal computed tomography for Case 2 revealed jejunal intramural hematoma and bloody ascites. The patient received
conservative therapy with nil by mouth, fresh frozen plasma transfusion, and vitamin K1 supplementation, and no surgical intervention was done
based on experience gained with the first case. Although a few other recent cases have been reported, the differences in our two cases were
especially helpful in demonstrating that surgery can be avoided. We suggest that a history of anticoagulant use with prolonged international
normalized ratio values in patients presenting with abdominal pain should alert physicians to consider spontaneous intramural small-bowel
hematoma secondary to warfarin therapy. Recognizing this syndrome is important in order to avoid unnecessary surgery because excellent
outcomes can be achieved with conservative treatment.
Copyright  2014, Taiwan Society of Emergency Medicine. Published by Elsevier Taiwan LLC. All rights reserved.
Keywords: Acute abdomen; Intramural hematoma; Small bowel; Warfarin1. Introduction
Although intramural small-bowel hematoma is a known
complication of blunt trauma, it is a lesser known rare
complication of excessive anticoagulant therapy, reported to
occur in only one case/2500 anticoagulated patients/year.1 The
most common complication of anticoagulant therapy is, of
course, bleeding, which can manifest as hematuria, gastroin-
testinal bleeding, epistaxis, soft tissue hematoma, and more
serious events such as cerebral hemorrhage.2 Although the
incidence is rare, warfarin-induced nontraumatic intramural* Corresponding author. Department of Surgery, Shin Kong Wu Ho-Su
Memorial Hospital, 95 Wen-Chang Road, Shih Lin, Taipei 111,Taiwan.
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http://dx.doi.org/10.1016/j.jacme.2014.01.001hemorrhage of the small bowel can cause intestinal ischemia,
obstruction, and ileus. Spontaneous small-bowel hematoma
typically involves the jejunum, which may be followed by
involvement of the ileum and duodenum. Elevated prothrom-
bin time (PT) and activated partial thromboplastin time
(APTT) as well as prolonged international normalized ratios
are characteristic signs. Diagnosis can usually be confirmed
with abdominal computed tomography (CT), which may
reveal circumferential wall thickening, intramural hyper-
density, luminal narrowing, and small bowel obstruction in
some cases.3 Early diagnosis is critical in order to avoid un-
necessary surgery because conservative management has been
shown to resolve the condition.4 Unfortunately, the condition
is not always included in the differential diagnosis of patients
admitted for emergent evaluation of acute abdomen. BesidesMedicine. Published by Elsevier Taiwan LLC. All rights reserved.
Fig. 1. Abdominal computed tomography demonstrating patency of mesentery
vessels (arrowhead) and segmental intramural hematoma affecting distal
jejunum (arrow).
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atrial fibrillation, other risk factors for intramural small-bowel
hematoma include chemotherapy, hemophilia, vasculitis,
idiopathic thrombocytopenia purpura, leukemia, lymphoma,
myeloma, pancreatitis, and pancreatic cancer.3
Several individual cases and case series of warfarin-
induced intramural small-bowel hematoma have been re-
ported in the past decade,4e9 but, due to the rarity of the
condition, only case studies have been published and long-
term comparative or observational studies of intramural he-
matoma in anticoagulated patients are not found. Two cases of
warfarin overdose were reported by Altinkaya et al,9 and both
were treated by immediately discontinuing warfarin therapy
followed by conservative management (vitamin K and fresh
frozen plasma) until mural thickening and ascites were
completely resolved. Another three cases were reported
recently by Samie et al,4 and all were complications of
phenprocoumon/warfarin therapy, which is being used exten-
sively for therapeutic and prophylactic purposes these days.
These authors predict that the incidence of spontaneous small-
bowel hematoma will increase along with increased long-term
anticoagulation therapy, especially in the growing elderly
population.
Herein, we report two cases of spontaneous nontraumatic
jejunal intramural hematoma presenting as acute abdomen,
both due to this rare, and possibly increasing, complication of
warfarin therapy.
2. Case reports2.1. Case 1Fig. 2. Histology revealed no thrombus was found in the mesentery vessels
(arrow; hematoxylin and eosin stain 40).An 83-year-old female had a history of previous cerebral
vascular accident with right middle cerebral artery hemor-
rhagic infarct. She had received warfarin therapy 5 mg four
times daily for 4 years for atrial fibrillation. Her coagulation
profile two months prior to the emergency visit included a PT
of 17.2 seconds, with international normalized ratio (INR) of
2.3. She was brought to the emergency room due to sudden
onset of abdominal pain for 1 day. Bilious vomiting accom-
panied by left lower abdominal tenderness and rebound
tenderness was found. Plain abdominal X-ray showed mark-
edly distended small bowel loops compatible with bowel
obstruction. Abdominal CT demonstrated segmental mural
thickening with precontrast hyperdensity and perienteric haz-
iness affecting the distal jejunum (Fig. 1). Blood examination
revealed: white blood cells, 18.4  109/L; segmented cells,
89%; elevated INR, 24.23, PT, 61.1 seconds (normal,
9.4e12.5 seconds); and APTT, 91.2 seconds (normal,
28.6e38.6 seconds). Even though no abdominal CT evidence
of bowel gangrene was detected, emergent laparotomy was
arranged under the impression of mesentery occlusion with
impending bowel ischemia due to her history of atrial fibril-
lation. At laparotomy, bloody ascites and ischemic and
gangrenous changes in the jejunum 80 cm distal to the Treitz
ligament were found. Segmental resection and primary anas-
tomosis were performed. Histology of the resected jejunumrevealed no thrombus in the mesentery vessels (Fig. 2).
Diffuse hemorrhage and necrosis were found at the mucosa
and submocosal layers (Fig. 3). The patient had an uneventful
recovery and was discharged in stable condition.2.2. Case 2A 77-year-old male was admitted to the emergency room
because of abdomen distension for 3 days. Abdominal pain
developed on the day of admission to the emergency room. He
had a history of hypertension, previous cerebrovascular acci-
dent, and atrial fibrillation. He had received warfarin 5 mg
four times daily beginning 5 years ago. He had also received
regular outpatient follow-up every 3 months. However, his last
coagulation profile dated 3 years previously showed a PT of
Fig. 3. Histology revealed diffuse hemorrhage (arrowhead) and necrosis at the
mucosa and submucosal layers (arrow; hematoxylin and eosin stain 40).
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abdominal distension with diffuse tenderness and rebound
tenderness. Fresh uncoagulated bloody ascites was found on
abdominal paracentesis. Laboratory data revealed: white blood
cells, 15.5  109/L; hemoglobin, 81 g/L, PT, 101.2 seconds;
APTT, 70.3 seconds; and INR, 8.72. Abdominal CT showed
jejunal intramural hematoma and bloody ascites (Fig. 4). After
the experience gained from Case 1, this patient was managed
differently. He was admitted and treated conservatively with
nil by mouth, fresh frozen plasma transfusion and vitamin K1
supplement. His general condition improved after 48 hours of
conservative treatment and he resumed eating 4 days after
admission. The patient was discharged in a stable condition.
3. Discussion
The exact pathogenesis of intramural hematoma associated
with warfarin therapy is unknown, and as evident in both ofFig. 4. Abdominal computed tomography demonstrating intramural hematoma
at the proximal jejunum (arrow).the present cases, trauma is not a related factor. In Case 1, an
abnormal coagulation profile was found even though the pa-
tient’s last PT and INR values were within the expected range
2 months prior to her admission for acute abdomen. Surgical
intervention was our decision for Case 1 based on the in-
dications, which classically include significant intramural
hemorrhage, bowel perforation, or ischemia.5 Case 1 had
mesentery ischemia with bowel gangrene, which is usually
considered in the initial differential diagnosis of patients with
acute abdomen who also have a medical history of atrial
fibrillation. However, we believe that the differential diagnosis
of nontraumatic spontaneous small bowel hematoma caused
by warfarin-induced overcoagulation should always be
included in evaluating such patients. Intestinal hematoma must
always be suspected as the cause of acute abdomen in patients
with a medical history of warfarin therapy and prolonged INR
value. The duration of warfarin use to the onset of acute
abdomen symptom varies from 8 days to 132 months.5
Patients with small bowel intramural hematoma usually
present with symptoms of abdominal distension, nausea,
vomiting, and abdominal pain. Cramping pain may also be
found because of partial intestinal obstruction. Gastrointestinal
hemorrhage, hematemesis, melena, or rectal bleeding is pre-
sent in less than half of these patients.3 Duration of acute
symptoms is usually a few days prior to patients seeking
medical assistance. Physical examination usually reveals
abdominal tenderness, localized or diffuse in varying degrees,
and with or without rebound tenderness. Laboratory tests
usually reveal abnormal PT, APTT, and INR values, and INR
>3 is associated with an increased risk of bleeding. Diagnostic
findings are usually presented in abdominal CT scans as mural
thickening of the small bowel without mesenteric vascular
occlusion.3 Characteristic findings are circumferential bowel
wall thickening, luminal narrowing, and intestinal tract
obstruction. Intraluminal hyperdensity corresponding to he-
matoma is present in about 40% of cases.3
In the hands of experienced surgeons and with appropriate
intervention, surgery may not be necessary and patients with
this rare complication of warfarin therapy can usually be
treated conservatively with smooth recovery after ruling out
other complications that may need laparotomy or further
investigation. The three cases reported by Samie et al4 pre-
sented, as did our cases, with acute abdomen, one with
accompanying jaundice and another with melena; the jejunum
was affected in two cases and the duodenum in the third. All
were diagnosed by abdominal ultrasound and CT; in one case,
the “ring sign” was seen on magnetic resonance imaging,
which helped to identify duodenal hematoma. Two of the
patients were successfully treated with conservative manage-
ment; the third required laparotomy due to worsening symp-
toms and possible peritoneal irritation. Similarly, our first case
received surgery in keeping with ischemic and gangrenous
changes, and Case 2 also had bloody ascites indicative of
ischemic changes but we applied conservative management
instead of surgery. The main reason for this was that Case 2
did not show pan peritonitis as Case 1 had; if, within 24 hours,
abdominal tenderness and rebound tenderness did not improve
48 C.-M. Ou Yang et al. / Journal of Acute Medicine 4 (2014) 45e48or even became exacerbated, we would have performed sur-
gery for Case 2 as well. The mainstay of conservative man-
agement is discontinuing warfarin, bowel rest, correction of
PT with intravenous vitamin K, and administration of fresh-
frozen plasma.6 As noted above, surgical intervention is
indicated only when there is significant intramural hemor-
rhage, bowel perforation or ischemia, and after any other
possible conditions requiring laparotomy have been excluded.
In Case 1, surgery was decided due to inexperience in the
evaluation and management of such patients. However, timely
surgical intervention with bowel resection still must be
considered if the patient shows clinical signs of deterioration.
With the experience gained in treating our first patient, the
second patient was treated conservatively and had a smooth
recovery.
Both physician and patient awareness of the risk of
bleeding when using warfarin is especially important for
elderly patients. A strong relationship is shown between the
intensity of anticoagulant therapy and risk of bleeding, espe-
cially in patients with deep vein thrombosis, tissue or me-
chanical heart valves, and prior gastrointestinal bleeding.10
Medications such as cimetidine, aspirin, anti-inflammatory
drugs, and antibiotics may increase the effects of warfarin.
Clear advice to older patients of the risk of nonadherence is
important in such cases.7 Coagulation parameters must also be
strictly monitored; during warfarin therapy, targeted PT and
APTT values should be within the normal ranges (9.4e12.5
seconds and 28.6e38.6 seconds, respectively); INR on
warfarin therapy, normally 2.0e3.5, may be 3.0e4.5.10
In conclusion, small bowel intramural hematoma present-
ing as ischemic bowel disease is a rare complication of
warfarin therapy and should be considered in the differential
diagnosis of acute abdomen patients receiving warfarin ther-
apy. Close monitoring of coagulation parameters are indicated
in these patients in order to prevent such complications. The
history of anticoagulant use with prolonged INR values in
patients presenting with abdominal pain should alert physi-
cians to search for this entity. The diagnosis is confirmed by
the spontaneous resolution of the findings on a follow-up CT
scan after several weeks.6 Therefore, it is extremely important
to recognize this syndrome in order to avoid unnecessarysurgery because excellent outcomes can be achieved with
conservative treatment. Because of the rarity of this compli-
cation of anticoagulation therapy, only case reports are found
in the literature. Future prospective studies of patients
receiving anticoagulation therapy are needed so that the
pathogenesis of intramural hematoma associated with warfarin
therapy can be elucidated.
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